Innovation at the Intersection - Frans Johansson
Medici and Karolinska Institutet hosted an interdisciplinary innovation session at the Karolinska Institutet Biomedicum.
The Medici Effect - Innovation at the Intersection keynote lecture together with an interactive method workshop immersed the participants in an innovation process. It leveraged the diversity perspectives and disciplines in the room, fuelling creativity and rapid ideation. The aim was that participants would leave the session having made groundbreaking connections and armed with tools to drive innovation and to unearth groundbreaking solutions in science.
This event was following the Nobel Conference (see attached programme below), both organized by: Professor Peter Stenvinkel & Associate Professor Karolina Kublickiene, CLINTEC, Renal Medicine & DEVREG Doctoral Programme. The programme generally aims to improve transferable skills and emphasise sex, gender & diversity dimension aspects in biomedical research.
The evening ended with a a screening of a short film about examples of opportunities in biomimetics by film producer and professor Claes Andren, CEO of Nature Artbevarande.
We are grateful for the support and collaboration of our partners to make this event possible: Akebia, AstraZeneca, Baxter, REATA and VINNOVA.
The Medici Experience is inspired by Medici Co-Founder and CEO, Frans Johansson’s best-selling book The Medici Effect (Harvard Business Press, 2004, re-published in 2017), which invites audiences to step into the intersection, a place where ideas from different disciplines, industries, and cultures collide to create innovation.
The Medici Group (Medici) is a global strategy firm that helps companies innovate by explicitly leveraging the diversity of their teams.
Frans Johansson is the founder and CEO of The Medici Group, where he advises executive leadership from some of the world's largest companies. He is also author to two books –The Medici Effect and The Click Moment– and an international speaker on the message that diversity drives innovation.